SEC Company Response from AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818) (AYTU) — Oct 3, 2018

AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)
Date: Oct. 3, 2018 · CIK: 0001385818 · Accession: 0001213900-18-013433

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-227243

Date

October 3, 2018

Author

Joshua R. Disbrow

Form

CORRESP

Company

AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)

Letter

Aytu BioScience, Inc.

373 Inverness Parkway, Suite 206

Englewood, CO 80112

October 3, 2018

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Attention: Irene Paik

Re: Aytu BioScience, Inc. – Registration Statement on Form S-1 (File No. 333-227243)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-227243), as amended (the “Registration Statement”) of Aytu BioScience, Inc. We respectfully request that the Registration Statement become effective as of 5:00 p.m., Eastern Time, on October 4, 2018, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Dorsey & Whitney LLP, by calling Anthony Epps at (303) 352-1109.

Very truly yours,
Aytu BioScience, Inc.

Show Raw Text

CORRESP
1
filename1.htm

Aytu BioScience,
Inc.

373 Inverness Parkway,
Suite 206

Englewood, CO 80112

October 3, 2018

VIA EDGAR

United States Securities
and Exchange Commission

Division of Corporation
Finance

100 F. Street, N.E.

Washington, D.C. 20549

Attention: Irene Paik

Re:  Aytu BioScience, Inc. – Registration Statement on Form S-1 (File No. 333-227243)

Ladies and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of
the Registration Statement on Form S-1 (File No. 333-227243), as amended (the “Registration Statement”) of Aytu BioScience,
Inc. We respectfully request that the Registration Statement become effective as of 5:00 p.m., Eastern Time, on October 4, 2018,
or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please confirm orally that
event with our counsel, Dorsey & Whitney LLP, by calling Anthony Epps at (303) 352-1109.

    Very truly yours,

    Aytu BioScience, Inc.

    By:
    /s/ Joshua R. Disbrow

    Name:
        Joshua R. Disbrow

    Title:
        Chairman and Chief Executive Officer

SecProbe.io